The $360 Billion Market that Medicine Got Wrong for 20 Years

Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?

Additional blockbuster drugs may be on the horizon.

After Harvey, vertical AI’s next $10B winner might be in agriculture

In legal, Harvey crossed an 11 billion valuation and Legora is racing to claim the European market behind it. In healthcare, Abridge has built a multi-billion-dollar business turning clinical conversations into structured medical records. In customer service, Sierra is now valued at over 15 billion, making it one of the fastest companies in AI history [] This story continues at The Next Web

Antibiotic resistance and E. coli: The hidden crisis fueling inflammatory bowel disease

(NaturalNews) The reckless overuse of broad-spectrum antibiotics, driven by Big Pharma's profit motive and corruption within medical and agricultural systems, h...

130 million kronor for global health

130 million kronor for global health

Ascendis Pharma: Behind The Stock Surge

Ascendis Pharma: Behind The Stock Surge

Ferraris and Shell Companies: Five Charged in Medicare Fraud Schemes

Medicare paid over 10 billion in 2024 for expensive wound coverings called skin substitutes, a sudden spending spike that analysts have called one of the largest examples of waste in the federal health program’s history. The spending was fueled by multiple kickback schemes that enriched both the companies that manufactured skin substitutes and the doctors []

Maharashtra FDA Acts Against Cadila Pharma; Bars Sale Of Two Sets Of Medicines

FDA Commissioner Tukaram Mundhe said confusion caused by similar brand names, which could lead doctors, pharmacists or patients to administer the wrong drug, amounted to a serious public health...

Vertex’s $10 Billion Crinetics Takeover Signals Pharma’s Biggest Rare Disease Bet Yet

Vertex Pharmaceuticals is making its largest acquisition ever, placing a massive 10 billion bet on rare endocrine diseases with the purchase of Crinetics Pharmaceuticals. The deal marks a major strategic shift for the biotechnology leader, which has built its empire around cystic fibrosis treatments but is now expanding aggressively into new high-value therapeutic areas. Under the agreement, Vertex will acquire Crinetics for 85 per share in cash, representing an equity value of approximately 10 billion. The transaction is expected to close in the third quarter of 2026 after receiving customary regulatory approvals. The acquisition gives Vertex access to Crinetics’ growing

Onitsha Medicine Market hands over fake, expired drugs worth N430m to NAFDAC

By Chimaobi Nwaiwu NNEWI — The leadership of the Ogbo Ogwu Medicine Market in Onitsha, Anambra State, has handed over fake, expired and other unwholesome drugs valued at more than N430 million to the National Agency for Food and Drug Administration and Control (NAFDAC) for destruction, as part of efforts to rid the market of [] The post Onitsha Medicine Market hands over fake, expired drugs worth N430m to NAFDAC appeared first on Vanguard News.

Broker’s Call: Mankind Pharma (Add)

InCred Equities

Doctors, nurses arrested in $6.5B global health care schemes

455 people, including doctors and nurse practitioners, were charged in connection with global health care fraud schemes totaling $6.5 billion. Read more: https://www.usatoday.com/story/news/nation/2026/06/24/health-care-fraud-case-takedown/90674073007/ Sign up for our newsletter for the day's top stories, from sports to movies to politics to world events: https://profile.usatoday.com/newsletters/daily-briefing/

Why Codifying Most Favored Nation Drug Pricing Would Be A Mistake

America’s drug pricing crisis is real. Patients skip doses, seniors split pills, and employers shoulder rising health costs year after year. That frustration has made the idea of Most Favored Nation drug pricing politically attractive: if other wealthy countries pay less, why shouldn’t the United States? The problem is that codifying MFN into law would [] Why Codifying Most Favored Nation Drug Pricing Would Be A Mistake

Health company accused of using fake doctors for sales

Australians with diabetes, heart disease, obesity and menopause paid thousands and spoke with fake doctors who said their lives were at risk, a watchdog claims.

Every euro invested in innovative medicines yields 5.67 euros, EFPIA finds

An analysis carried out across 29 European countries between 2014 and 2024 quantifies, for the first time, the economic and social value of pharmaceutical innovation: 66 billion euros in total benefits, comprising hospital savings and productivity gains

White House Secretly Scraps RFK Jr.’s Ad Blitz After ICE Barbie Disaster

Reuters/ Pic MonkeyRobert F. Kennedy Jr. has lost the chance to roll out his own commercials after Kristi Noem’s controversial ad campaign went too far.The health secretary had big plans for a “Take Back Your Health” initiative featuring “bold, edgy” TV and digital ads warning about the dangers of processed foods, but the campaign was canceled weeks ago after concerns over Noem’s widely criticized anti-immigration ad campaign, according to NOTUS.RFK Jr.’s planned four-year public relations campaign was announced last year with an estimated budget of 10 million to 20 million.Read more at The Daily Beast.

Doctors and pharmacists ran fake prescription racket, with damages above €400,000

The ringleader has been arrested, while another nine people are named in the case file, including a psychiatrist and a doctor at a public hospital. More than 5,400 fake prescriptions have been identified The post Doctors and pharmacists ran fake prescription racket, with damages above 400,000 appeared first on ProtoThema English.

Cholesterol and Heart Medications Were Recalled Early This Year — Here Is What Statin Users Should Check

AvKARE recalled rosuvastatin and Zydus recalled Icosapent Ethyl tablets early 2026 for manufacturing defects. Here are the affected lot numbers and what heart medication patients should do.

UNODC World Drug Report 2026: Global drug markets transforming rapidly as technology, novel drug types and instability present traffickers with new opportunities

UNODC World Drug Report 2026: Global drug markets transforming rapidly as technology, novel drug types and instability present traffickers with new opportunities

Americans Are Rethinking Supplements — This 25-Year Study Explains Why

Enter: The rise of personalized supplementation

Bedblock-busting pilot program aims to aid hundreds of stranded aged-care patients

There’s 10.3 billion extra for the health system, but from transport to housing and schools and western Sydney, here’s where else the money is being spent.

Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal Manchanda

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and consumer healthcare. While US FDA approvals for complex generics remain a challenge, innovation and contract manufacturing offer significant future profit pools. Experts anticipate biosimilars could generate substantial revenue, and despite a slow start, GLP-1 drugs show long-term promise. Sun Pharma is highlighted as a preferred domestic investment.

US projected to spend nearly $9 trillion on healthcare by 2034

The U.S. is expected to spend nearly 9 trillion on healthcare by 2034, according to a new report released Wednesday. The nation’s healthcare spending is also projected to account for 20.6 of the total economy, according to a report published in Health Affairs citing Centers for Medicare and Medicaid Services data. In 2024, the nation’s []...Click to read more

Pfizer's experimental lung cancer drug fails to extend survival in late-stage trial

The drug, acquired in Pfizer's 43 billion purchase of Seagen, did not outlast standard chemotherapy in a 703-patient study

Washington’s bet on hospital prices blew up in its face

Washington made a bet. Force hospitals to post their prices, the theory went, and a real market would form and pull costs down. Five years on, the files are posted. The market never formed. Prices never fell. The disclosed data now run to enormous scale. Yet when researchers examined the posted files, they could not []

China AI drug-design deals swell as US scrutiny mounts

Riding a wave of booming cross-border dealmaking, China’s AI-driven drug-design firms are charging onto the global stage despite Washington’s growing scrutiny of Chinese biotech firms. The value of out-licensing deals struck by Chinese biotech companies with top global multinational pharmaceutical companies climbed to US75 billion in the first five months of 2026, up from zero before 2020, according to Linda Shu, head of China healthcare research at HSBC. In total, over the five months, these...

This Travel-Ready Beauty Kit Is 50% Off & Made for Hot Summer Days

Is there anything better than a good deal? Not in our shopping-obsessed world! It's especially excellent when the good deal in question is on an eight-piece skincare and bodycare set. We found the...

The Role of Technology Errors in Patient Harm

When it comes to embracing innovation, there is often the “wow” factor that may cause excessive optimism and undue reliance on unproven technology. If you or someone you love was harmed by technology or the misuse of medical technology, this will be helpful information. Malpractice Increases In America, medical malpractice claims cost 8.9 billion per []

Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage

Many Americans are shopping around for affordable options as the cost of health insurance soars. But some who hope to keep the same doctors and medications face a thicket of red tape and disruption after they switch plans.

वीर र ट्रमा सेन्टरमा ‘सुलभ फार्मेसी’

काठमाडौँ। वीर अस्पताल र राष्ट्रिय ट्रमा सेन्टरमा सुलभ फार्मेसी सञ्चालनमा आएको छ। नेपाल सरकार मन्त्रिपरिषद्को १३ चैत २०८२ को बैठकबाट स्वीकृत शासकीय सुधारसम्बन्धी एक सय कार्यसूचीमध्ये बुँदा नम्बर ८५ (घ) अन्तर्गत सरकारी अस्पतालमा सुलभ फार्मेसी सञ्चालन तथा विस्तार गर्ने सुधार कार्यक्रमअनुसार यो सेवा सञ्चालनमा ल्याइएको हो। मन्त्रालयले सरकारी अस्पतालमा सहुलियत दरमा गुणस्तरीय औषधि उपलब्ध गराई []

Why is Orthofix Medical stock surging today?

Why is Orthofix Medical stock surging today?

A lifetime habit just outperformed every Alzheimer’s drug ever approved

(NaturalHealth365) Billions of dollars have gone into finding a drug that slows ... A lifetime habit just outperformed every Alzheimer’s drug ever approved The post A lifetime habit just outperformed every Alzheimer’s drug ever approved appeared first on NaturalHealth365.